Radionuclide therapy revisited
CA Hoefnagel - European journal of nuclear medicine, 1991 - Springer
Apart from its use in endocrinology and rheumatology, therapeutic nuclear medicine is
developing rapidly as an additional treatment modality in oncology. Many different specific …
developing rapidly as an additional treatment modality in oncology. Many different specific …
Radioiodine therapy of thyroid disease
WH Beierwaltes - International Journal of Radiation Applications and …, 1987 - Elsevier
Ten “ideal” steps used at the University of Michigan to treat well-differentiated thyroid cancer
are presented. Using this in 103 patients with well-differentiated thyroid carcinoma and …
are presented. Using this in 103 patients with well-differentiated thyroid carcinoma and …
[PDF][PDF] Iodine-131 contamination from thyroid cancer patients
E Ibis, CR Wilson, BD Collier, G Akansel… - Journal of Nuclear …, 1992 - Soc Nuclear Med
MATERIALS AND METHODS Eightpatientswiththyroidcancertreatedwitha…@ I ranging from
3.7 — 14.8 GBq volunteeredto participate in this study. The ages ranged from 13 to 67 yr …
3.7 — 14.8 GBq volunteeredto participate in this study. The ages ranged from 13 to 67 yr …
[图书][B] Manual of endocrine surgery
AJ Edis, CS Grant, RH Egdahl - 2012 - books.google.com
Introduction Anthony J. Edis, Richard H. Egdahl, Tracy K. Mcintosh, Contents Lester F.
Williams xi 1 Surgery of the Parathyroids General Introduction 1 SURGICAL ANATOMY …
Williams xi 1 Surgery of the Parathyroids General Introduction 1 SURGICAL ANATOMY …
[图书][B] Nuklearmedizin
K Zum Winkel - 2013 - books.google.com
In den vergangenen 15 Jahren hat sich die Nuklearmedizin beträchtlich weiterentwickelt
und in verschiedenen Bereichen verändert. Neue Radiopharmaka wurden eingeführt, neue …
und in verschiedenen Bereichen verändert. Neue Radiopharmaka wurden eingeführt, neue …
Therapy-related acute myeloid leukemia following radioactive iodine treatment for thyroid cancer
Background Therapy-related acute myeloid leukemia (t-AML) associated with radioiodine
treatment (RAI) is emerging as an important clinical entity with the rise in incidence of thyroid …
treatment (RAI) is emerging as an important clinical entity with the rise in incidence of thyroid …
Management of adrenal neoplasms
RF Pommier, MF Brennan - Current problems in surgery, 1991 - Elsevier
The purpose of this monograph is to present the current surgical knowledge on the
management of adrenal neoplasms. The adrenal neoplasms discussed herein have been …
management of adrenal neoplasms. The adrenal neoplasms discussed herein have been …
[PDF][PDF] Horizons in radionuclide therapy: 1985 update
WH Beierwaltes - Journal of nuclear medicine, 1985 - Soc Nuclear Med
The therapeutic approach of internally adminis tered radiopharmaceuticals offers the
potential to outmode the present approaches of conventional ra diation therapy and …
potential to outmode the present approaches of conventional ra diation therapy and …
Disseminated malignant phaeochromocytoma: localisation with iodine-131-labelled meta-iodobenzylguanidine.
H Sutton, P Wyeth, AP Allen, OA Thurtle… - Br Med J (Clin Res …, 1982 - bmj.com
Meta-iodobenzylguanidine, a guanethidine analogue, is a newly synthesised substance
capable of imaging the adrenal medulla. In a woman in whom phaeochromocytoma has …
capable of imaging the adrenal medulla. In a woman in whom phaeochromocytoma has …
Radioiodine-Labeled Meta-Iodobenzylguanidine for Imaging and Treatment of Pheochromocytoma/Paraganglioma and Neuroblastoma
M Fischer, M Schmidt - Beyond Becquerel and Biology to Precision …, 2024 - Springer
Following the new WHO classification of tumors of the endocrine organs (Lloyd RV,
Osamura RY, Klöppel G, Rodai J, editors. WHO classification of tumours of endocrine …
Osamura RY, Klöppel G, Rodai J, editors. WHO classification of tumours of endocrine …